Clinical geneticists and obstetric specialists reporting in Molecular Cytogenetics have documented the antenatal identification and tissue-specific postmortem characterization of mosaic trisomy 14 in a fetus presenting with an early-onset, severe malformative syndrome. Trisomy 14 mosaicism is an exceptionally uncommon chromosomal disorder defined by the presence of an extra fourteenth chromosome in a subset of cellular lineages, while the remaining cells maintain a typical disomic complement. The true biological prevalence of this condition remains uncertain across human populations because complete or extensive trisomy involving chromosome 14 frequently results in early spontaneous miscarriage during the initial weeks of gestation. Published literature indicates an apparent three-to-one female-to-male ratio among documented individuals, highlighting the unusual nature of identifying this disorder in an affected male fetus. Across prior clinical descriptions, individuals carrying mosaic trisomy 14 display a highly variable spectrum of physical and developmental manifestations, encompassing intrauterine growth restriction, diverse craniofacial dysmorphic characteristics, congenital cardiac malformations, and genitourinary defects, without demonstrating a consistent numerical correlation between the percentage of abnormal cells and phenotypic severity.
The pregnancy under investigation involved a woman in her thirties undergoing her second gestation, having previously delivered a healthy three-year-old son, with no known parental consanguinity or familial history of congenital disorders. The maternal medical history was notable for Graves’ disease managed pharmacologically with propylthiouracil. Early routine prenatal screening conducted during the first trimester triggered initial diagnostic concern when an abdominal sonographic examination performed using a dedicated Voluson system revealed an increased nuchal translucency measuring 2.6 millimeters alongside a fetal crown-rump length of 51.4 millimeters, placing the measurement between the ninety-fifth and ninety-ninth percentiles. Concurrent biochemical evaluation of maternal serum markers yielded atypically suppressed concentrations, with pregnancy-associated plasma protein A registering at 0.18 multiples of the median and free beta-human chorionic gonadotropin measuring 0.15 multiples of the median. When computed jointly, these sonographic and biochemical parameters generated an estimated combined risk for chromosomal aneuploidy of 1 in 16, establishing a high-risk classification that warranted invasive prenatal diagnostic testing via chorionic villus sampling at fifteen weeks of gestation.
Genomic investigation of the native chorionic villi commenced using array comparative genomic hybridization on extracted trophoblastic deoxyribonucleic acid. The hybridization profile demonstrated a complete and homogeneous duplication across chromosome 14, yielding an elevated log-ratio of 0.541. From this quantitative log-ratio metric, the laboratory team extrapolated a theoretical mosaicism level of approximately 91 percent within the native chorionic tissue sample. However, taking into account the biological mechanisms driving chromosome 14 malsegregation alongside the recognized technical limitations of array comparative genomic hybridization in defining whole-chromosome cellular ratios, the authoritative cytogenetic profile was assigned according to the International System for Human Cytogenetic Nomenclature 2024 guidelines as arr(14)x3. High-resolution microarray analysis revealed no additional pathogenic or likely pathogenic copy number variations elsewhere in the fetal genome. Parallel attempts to establish primary cellular cultures from the villus sample proved unsuccessful, failing to generate usable mitotic spreads for conventional metaphase karyotypic confirmation.
A specialized referral ultrasound performed at 15 weeks plus one day of gestation using multi-modal Doppler sonography uncovered a complex constellation of structural malformations. Craniofacial imaging demonstrated a clear unilateral cleft lip, while examination of the fetal extremities revealed a marked positional deformity of the left foot displaying a varus appearance alongside an abnormal widening of the first interdigital space of the right foot. Focused fetal echocardiography revealed an intricate cardiac defect characterized by hypoplasia of the pulmonary artery, visible as a slender pulmonary trunk and a thin left pulmonary artery branch, in conjunction with a ventricular septal defect and an aberrant right-sided aortic arch. Sonographic biometric assessment further documented severe intrauterine growth restriction falling at the third percentile, which predominantly compromised abdominal circumference and femoral development. Given the profound severity and multiplicity of these structural anomalies, the parents elected to proceed with pregnancy termination, which was carried out at 17 weeks plus four days of gestation.
Following parental consent restricted to external examination, skeletal radiography, and tissue biopsy without complete visceral autopsy, postmortem fetopathological evaluation confirmed a severely affected male fetus weighing 109.3 grams, representing a negative deviation of 1.71 standard deviations relative to gestational age norms. Linear dimensions demonstrated proportional somatic reduction, with a crown-heel length of 180 millimeters at minus 1.61 standard deviations, a crown-rump length of 120 millimeters at minus 1.71 standard deviations, a foot length of 21 millimeters at minus 1.25 standard deviations, and a head circumference of 135 millimeters at minus 0.62 standard deviations. External inspection revealed malar hypoplasia and hypertelorism, while ocular globes appeared normal. Auricular evaluation showed low-set, posteriorly rotated ears with patent external auditory canals. Examination of the oral cavity confirmed a right-sided cleft lip and alveolus extending into a posterior cleft palate beneath a high-arched anterior palate, accompanied by mild micro-retrognathia. Skeletal examination identified bilateral clubfoot and clinodactyly of the fifth fingers, alongside closely spaced nipples and a prominent sacrococcygeal dimple. The male external genitalia exhibited profound structural anomalies, including a bifid scrotum, a foreshortened and curved genital tubercle, hypospadias, and an anteriorly displaced anus.
Postmortem skeletal radiographs corroborated the physical findings while identifying distinctive axial skeletal disruptions. Imaging demonstrated marked segmented platyspondyly characterized by structural malformations of the vertebral bodies clustered predominantly at the thoracolumbar junction. The affected vertebral segments exhibited abnormally concave endplates producing a classic fish-vertebra configuration, alongside an intact nasal bone with a depressed nasal bridge. Radiographic measurement of the femur yielded a length of 18 millimeters, falling below the third percentile for seventeen weeks of gestation, though mineralization and bone maturation appeared structurally normal. Macroscopic and histological analysis of the placenta identified a normally configured organ with a weight situated near the tenth percentile for gestational age, displaying neither macroscopic lesions nor microscopic pathological alterations. Cytogenetic analysis of both parents demonstrated normal constitutional karyotypes, ruling out parental balanced structural rearrangements or inherited Robertsonian translocations as the underlying driver of the fetal anomaly.
To definitively assess the distribution of the aneuploidy within true fetal tissues rather than extra-embryonic trophoblastic lineages, investigators performed interphase fluorescence in situ hybridization on a fetal quadriceps muscle biopsy. The laboratory utilized a dual-probe hybridization strategy combining a red subtelomeric 14qter probe targeting the 14q32.33 locus with a green bacterial artificial chromosome probe designated RP11-642H22. Double-blinded enumeration of 248 cell nuclei revealed three red and three green hybridizing signals in 87 cells, establishing that mosaic trisomy 14 was present in approximately 35 percent of the examined fetal skeletal muscle nuclei. The formal cytogenetic formula was cataloged as nuc ish(RP11-642H22,dJ820M16)x3[87/248]. This marked numerical discrepancy between the 91 percent extrapolated mosaicism observed in native chorionic villi and the 35 percent mosaic level measured in fetal muscle tissue underscores the profound lineage divergence that can arise during early embryonic development following an initial post-zygotic rescue or mitotic segregation error.
Reviewing previous literature, the investigators noted that a 2013 review by Chen and colleagues identified significant phenotypic abnormalities in at least half of antenatally detected mosaic trisomy 14 cases, featuring growth impairment, microcephaly, facial dysmorphism, central nervous system alterations, cardiac defects, genital abnormalities, and polyhydramnios. Expanding on this work, the authors identified fourteen previously published prenatal cases across medical databases, establishing their patient as the fifteenth reported antenatal case. A prominent theme across these historical cases is the absence of a linear relationship between the proportion of trisomic cells in accessible diagnostic specimens and the severity of fetal malformations. For instance, in one historical case reported by Cheung and colleagues, an amniocentesis revealed only a 9 percent mosaicism rate, yet the infant suffered fatal multiorgan anomalies including Pierre Robin sequence, renal agenesis, and congenital heart defects, ultimately showing 37 percent mosaicism in blood and 0 percent in skin. Conversely, a case reported by Lambert and colleagues demonstrated mosaicism levels exceeding 60 to 70 percent on repeated amniocentesis despite entirely normal fetal sonographic anatomy and only mild isolated micrognathia at autopsy.
The biological mechanisms underlying this wide clinical variation relate directly to embryonic lineage allocation and genomic imprinting on chromosome 14. Mosaic trisomy 14 most commonly originates from the post-zygotic partial loss of an extra chromosome from an initially trisomic conceptus, an event known as trisomy rescue, or less frequently from a mitotic non-disjunction error arising in an initially normal disomic zygote. When trisomy rescue occurs, it can inadvertently produce uniparental disomy, leading to recognized imprinting syndromes such as Kagami-Ogata syndrome or Temple syndrome depending on whether the retained homologous chromosomes are of paternal or maternal origin. Furthermore, if the extra chromosome is lost unevenly across embryonic precursor pools, the relative burden of trisomic cells will diverge sharply among the ectodermal, mesodermal, and endodermal germ layers. Because standard clinical sampling techniques such as amniocentesis or chorionic villus sampling examine restricted cell lineages, they cannot capture the mosaic burden residing in critical developing organs like the embryonic myocardium or neuroectoderm.
To investigate whether placental involvement correlates with specific pathological changes, the authors conducted a ten-year retrospective audit of their medical center’s cytogenetic records, identifying only three prenatally diagnosed trisomy 14 cases. In two cases with complete placental pathological assessments, including the index patient and another displaying 10 percent amniotic mosaicism, the placentas showed no macroscopic or histological lesions. A third retrospective case demonstrated complete confined placental mosaicism with a 47,XY,+14 karyotype restricted to the cytotrophoblast, normal disomic cells within the mesenchymal core and amniotic fluid, and a structurally normal placenta upon gross examination. Together, these clinical observations emphasize that early detailed ultrasound remains indispensable for detecting structural malformations in rare aneuploidies where cytogenetic ratios in routine prenatal fluids fail to predict clinical outcomes. The authors conclude that integrating advanced early ultrasound surveillance with multi-tissue postmortem cytogenetic evaluation provides critical diagnostic clarity and improves genetic counselling for families facing complex chromosomal mosaicism.
Subject of Research: Prenatal diagnosis and fetopathological characterization of mosaic trisomy 14
Article Title: Antenatal discovery of mosaic trisomy 14 in an early-onset malformative syndrome
Article References: Martineau, R., Fuchs, F., Lamouroux, A., Ganne, B., & Wells, C. (2026). Antenatal discovery of mosaic trisomy 14 in an early-onset malformative syndrome. Molecular Cytogenetics, 19(1), Article 24. https://doi.org/10.1186/s13039-026-00763-6
Image Credits: AI Generated
DOI: 10.1186/s13039-026-00763-6
Keywords: mosaic trisomy 14, prenatal diagnosis, chorionic villus sampling, array comparative genomic hybridization, fluorescence in situ hybridization, first-trimester screening, fetal growth restriction, congenital heart defects, craniofacial dysmorphia, nuchal translucency, confined placental mosaicism, cytogenetics, fetal pathology, uniparental disomy, platyspondyly, hypospadias, ultrasound anomalies

